[Elsevier] The programmed site-specific delivery of LY3200882 and PD-L1 siRNA boosts immunotherapy for triple-negative breast cancer by remodeling tumor microenvironment

jean38330 Post time 2026-8-17 04:05:55 | Show all posts |Read mode
This post will be closed automatically in 2026-08-20 04:05
Reward10points

journalㄩBiomaterials

AuthorsㄩPan Zhang; Chao Qin; Nan Liu; Xinyuan Zhou; Xuxin Chu; Fangnan Lv; Yongwei Gu; Lifang Yin; Jiyong Liu; Jianping Zhou; Meirong Huo

Published dateㄩ2022-5-

DOIㄩ10.1016/j.biomaterials.2022.121518

PDF linkㄩhttps://www.sciencedirect.com/sc ... 142961222001570/pdf

Article linkㄩhttps://doi.org/10.1016/j.biomaterials.2022.121518

Article SourceㄩElsevier BV


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
isatdak97 Post time 2026-8-17 04:05:56 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    253


Return to the list